Share on StockTwits

Synergy Health Plc (LON:SYR)‘s stock had its “hold” rating restated by research analysts at N+1 Singer in a report released on Friday, Analyst RN reports. They currently have a GBX 1,200 ($19.78) price objective on the stock. N+1 Singer’s target price points to a potential downside of 3.85% from the company’s current price.

Shares of Synergy Health Plc (LON:SYR) opened at 1264.00 on Friday. Synergy Health Plc has a 1-year low of GBX 964.082 and a 1-year high of GBX 1257.00. The stock has a 50-day moving average of GBX 1145. and a 200-day moving average of GBX 1107.06. The company’s market cap is £740.7 million.

Several other analysts have also recently commented on the stock. Analysts at Investec raised their price target on shares of Synergy Health Plc from GBX 1,165 ($19.20) to GBX 1,400 ($23.07) in a research note to investors on Friday. They now have a “buy” rating on the stock. Separately, analysts at Nplus1 Brewin downgraded shares of Synergy Health Plc to a “hold” rating in a research note to investors on Friday, December 20th. They now have a GBX 1,200 ($19.78) price target on the stock, down previously from GBX 1,220 ($20.11). Finally, analysts at Numis Securities Ltd reiterated a “buy” rating on shares of Synergy Health Plc in a research note to investors on Tuesday, December 17th. They now have a GBX 1,300 ($21.42) price target on the stock. Four equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus price target of GBX 1,189.14 ($19.60).

Synergy Health plc delivers a range of specialist outsourced services to healthcare providers and other customers concerned with health management.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.